Max

2.3K posts

Max banner
Max

Max

@MaxSaeed00

I love Stonks.... 🦈 Nothing I do/say/share is a financial or life advice. It's my own vision for my own money & it might not be suitable for you & your money

Washington DC Katılım Temmuz 2011
42 Takip Edilen275 Takipçiler
Max
Max@MaxSaeed00·
Trying to think if I ever setup & forgot a wallet back in 2010 with 200,000 #BTC. Maybe somewhere in dreams 🙄
English
0
0
0
8
Max
Max@MaxSaeed00·
$AULT did anyone receive divident $IMHC shares?
English
0
0
1
237
Max
Max@MaxSaeed00·
@MaryMichelleNay Trust is the key... I support your struggle... Wanna see you win 🌹
English
0
0
0
24
Max
Max@MaxSaeed00·
@MaryMichelleNay Holding a bunch of them since my high school. Not sure if Todd would let them fly ever 😉
English
0
0
0
22
Max
Max@MaxSaeed00·
@MaryMichelleNay My friend blushed and said "wow, interesting" but did the shares available to short increased or decreased today? Which ia good or bad? Asking this for another friend (who is 5 years old)... 👀
English
0
0
0
71
Max
Max@MaxSaeed00·
@MaryMichelleNay Yeah but you were taking about some "short squeeze" for $AULT, what was that about? Asking for a friend 🤔
English
0
0
0
191
Max
Max@MaxSaeed00·
$NMHI 🚀🚀🚀
QME
2
0
0
207
Max
Max@MaxSaeed00·
$MDAI there seems to be confusion between @Spectral_MDAI & @MindAIProject. Can anyone clarify/point it out to both the companies?
English
1
0
2
85
Max
Max@MaxSaeed00·
$LENZ & $NMHI both need a bit of attention to take off
English
0
0
1
357
Max retweetledi
Arlo Oscar
Arlo Oscar@Oscar_arlo·
$NMHI zombie despac Ready for a 100% run
English
0
1
3
435
Max
Max@MaxSaeed00·
$NMHI LFG 🚀🚀🚀
Max tweet media
0
0
0
228
Max retweetledi
Major Gainz7
Major Gainz7@MajorGainz7·
$Lenz looking good here Fda phase 3 check it out below Lenz-tx.com
Major Gainz7 tweet mediaMajor Gainz7 tweet media
English
0
1
3
550
Max retweetledi
Major Gainz7
Major Gainz7@MajorGainz7·
$Lenz phase 3 deal in place with China $95 million
Major Gainz7@MajorGainz7

$Grph $Lenz In China, development partner Shanghai-based Ji Xing Pharmaceuticals is carrying out a Phase III trial (NCT06045299) on the efficacy and safety of LNZ101 and LNZ100. Ji Xing signed an exclusive license agreement last year to co-develop the two presbyopia eye drop treatments, agreeing to pay LENZ $15 million upfront; up to $95 million in payments tied to achieving development, regulatory, and commercial milestones; and royalty payments based on future net sales.

English
0
1
1
640

Keşfet

@JeffsBrands @NasdaqExchange @Spectral_MDAI @MindAIProject @elonmusk @BarackObama @taylorswift13 @cristiano